Parkinson's patients get chance to safely stop experimental brain treatment
NCT ID NCT07214285
Summary
This study follows Parkinson's patients who have been receiving an experimental brain treatment for several years. Researchers want to safely help patients stop this treatment by gradually reducing their dose and switching to alternative medications. The main goal is to monitor safety during this transition period and understand what happens when the treatment is discontinued.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UHLillle
RECRUITINGLille, Haut de France, 59000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.